Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...
Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price objective upped by UBS Group from $700.00 to $715.00 in a research note released on Friday morning,Benzinga reports. The brokerage ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...
Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per ...
Thermo Fisher Scientific Inc. ( NYSE: TMO) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO ...
Earlier this week, Franco-German peer Sartorius reported preliminary annual results that beat expectations and posted a 23.1% ...
10d
Strong demand, biotech funding optimism, and a bold 2025 outlook fuel investor confidence--here's what you need to know.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback